Skip to content

Workplace Smoking Cessation Intervention and Effectiveness Evaluation for Chinese Smokers Based on Behavioral Economics

Workplace Smoking Cessation Intervention and Effectiveness Evaluation for Chinese Smokers Based on Behavioral Economics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093891
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-12-16
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Dependence

Interventions

Control Intervention Group:Each intervention subject received regular cessation intervention information through the mini-program during the follow-up period.
Financial Commitment Intervention Group:Deposit 150 yuan in cash in the virtual account in advance when joining the group. On this basis, the intervention team will deposit a virtual amount of 450 yua
Nicotine patch intervention group:The intervention subjects randomly assigned to this group will receive nicotine patch intervention.
Economic incentive + nicotine patch intervention group:The intervention subjects randomly assigned to this group will receive nicotine patch intervention. Moreover, 150 yuan in cash will be deposited

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Positive cotinine saliva test, and an average of more than 5 cigarettes per day in the past month; Age between 18 and 65 years old; Active to quit smoking; Signed informed consent form;

Exclusion criteria

Exclusion criteria: Unable to receive messages from the smoking cessation WeChat public account on the mobile phone; Having participated in or currently participating in smoking cessation or other intervention studies; Diagnosed with severe mental disorders such as schizophrenia or bipolar disorder; The intervention subjects reported having a history of severe allergies, poor asthma control, or sudden cardiovascular and cerebrovascular disease events within the two weeks prior to enrollment; Presence of contraindications for transdermal nicotine patch therapy (such as latex allergy); Pregnant women, women planning to become pregnant, or nursing mothers; Researchers consider other reasons that make participation in the trial unsuitable.

Design outcomes

Primary

MeasureTime frame
6-month abstinence rate from smoking;

Secondary

MeasureTime frame
1-month abstinence rate from smoking;3-month abstinence rate from smoking;12-month abstinence rate from smoking;delay discounting rate;

Countries

China

Contacts

Public ContactYang Lian

Chengdu University of Traditional Chinese Medicine; Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

yyanglian@163.com+86 1340359258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026